- Report
- November 2023
- 185 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Report
- October 2023
- 190 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Report
- October 2023
- 189 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Report
- October 2023
- 181 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Report
- May 2024
- 133 Pages
Global
From €6275EUR$6,499USD£5,313GBP
- Report
- May 2024
- 138 Pages
Global
From €6275EUR$6,499USD£5,313GBP
- Report
- May 2024
- 128 Pages
Global
From €6275EUR$6,499USD£5,313GBP
- Report
- May 2024
- 133 Pages
Global
From €6275EUR$6,499USD£5,313GBP
- Report
- May 2024
- 132 Pages
Global
From €6275EUR$6,499USD£5,313GBP
- Report
- May 2024
- 133 Pages
Global
From €6275EUR$6,499USD£5,313GBP
- Report
- May 2024
- 139 Pages
Global
From €6275EUR$6,499USD£5,313GBP
- Report
- May 2024
- 135 Pages
Global
From €6275EUR$6,499USD£5,313GBP
- Report
- May 2024
- 137 Pages
Global
From €6275EUR$6,499USD£5,313GBP
- Report
- May 2024
- 129 Pages
Global
From €6275EUR$6,499USD£5,313GBP
- Report
- May 2024
- 137 Pages
Global
From €6275EUR$6,499USD£5,313GBP
- Report
- September 2023
- 146 Pages
Global
From €2413EUR$2,499USD£2,043GBP
- Report
- May 2024
- 185 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Report
- October 2023
- 181 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Report
- October 2023
- 190 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Report
- October 2023
- 162 Pages
Global
From €2414EUR$2,500USD£2,044GBP
![Loading Indicator](//www.researchandmarkets.com/images/loading.gif)
The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems.
Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea.
Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more